Companies

GSK plc (GSK) SEC filings

CIK 0001131399 · Pharmaceutical Preparations (SIC 2834) · NYSE, OTC · incorporated in X0

Latest filings

FiledFormDescriptionPeriod
2026-10-196-KJEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER2026-10-19
2026-10-196-KRIS-REZ POSITIVE EARLY DATA IN LUNG CANCER2026-10-19
2026-10-156-KDIRECTOR/PDMR SHAREHOLDING2026-10-15
2026-10-146-KDIRECTOR/PDMR SHAREHOLDING2026-10-14
2026-10-13S-8S-8
2026-10-136-KDIRECTOR/PDMR SHAREHOLDING2026-10-13
2026-10-136-KDIRECTOR/PDMR SHAREHOLDING2026-10-13
2026-10-086-KWENDY BECKER CBE - NEW DIRECTORSHIP2026-10-08
2026-10-066-KADMISSION TO TRADING2026-10-06
2026-10-016-KTOTAL VOTING RIGHTS2026-10-01
2026-09-246-KDIRECTOR/PDMR SHAREHOLDING2026-09-24
2026-09-22CERTNYSE CERTIFICATION
2026-09-226-KDIRECTOR/PDMR SHAREHOLDING2026-09-22
2026-09-158-A12B8-A12B
2026-09-156-K6-K2026-09-15
2026-09-156-KGSK TO ACQUIRE T CELL-ENGAGER FOR MULTIPLE MYELOMA2026-09-15
2026-09-146-KRIS-REZ POSITIVE PH 3 OS LUNG CANCER DATA IN CHINA2026-09-14
2026-09-146-KJIDEYTRO POSITIVE DATA FOR ROS1-POSITIVE NSCLC2026-09-14
2026-09-116-KDIRECTOR/PDMR SHAREHOLDING2026-09-11
2026-09-106-KDIRECTOR/PDMR SHAREHOLDING2026-09-10
2026-09-10424B2424B2
2026-09-106-KJAPAN APPROVAL OF SHINGRIX IN A PREFILLED SYRINGE2026-09-10
2026-09-096-KDIRECTOR/PDMR SHAREHOLDING2026-09-09
2026-09-096-KDIRECTOR/PDMR SHAREHOLDING2026-09-09
2026-09-09FWPFWP

Forms on file (last 1,000): 6-K 905, SC 13D/A 13, 11-K 8, SC TO-T/A 6, SC TO-C 5, 25-NSE 5, SC 13G/A 5, 4 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=GSK (0.002 USD), /gw/filings/filings?ticker=GSK&form=8-K, /gw/filings/facts?ticker=GSK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange